-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
November 12, 2019 - relative 3
Ovarian cancer onset age, y
<40 6
40-60 4
>60 2
Prostate cancer onset
Age <50 y 1
Colon … Evaluation of psychosocial effects of
pre-symptomatic testing for breast/ovarian and
colon cancer pre-disposing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-transitions-of-care-disposition-120504.pdf
October 01, 2011 - lump together MI, ischemic
stroke and hemorrhagic stroke into one document would be like
comparing colon
-
ce.effectivehealthcare.ahrq.gov/hai/tools/surgery/modules/on-boarding/overview-fac-notes.html
December 01, 2017 - Second, we will focus on emerging evidence like selective use of bowel preps for colon surgery, antibiotic
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - 11
If the patient does not
improve after 3 to 5 days, colectomy (i.e., surgical removal of the colon
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - Cholesterol, weight, height,
Quetelet's index, and colon cancer recurrence.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - 11
If the patient does not
improve after 3 to 5 days, colectomy (i.e., surgical removal of the colon
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - Cholesterol, weight, height,
Quetelet's index, and colon cancer recurrence.
-
effectivehealthcare-admin.ahrq.gov/products/weight-gain-prevention/research-protocol
December 01, 2019 - Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/bacterial-vaginosis-pregnancy-prevent-preterm-delivery-screening-2001
January 01, 2001 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: Screening, 2001
January 01, 2001
Recommendations made by the USPSTF are independent of…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
December 20, 2017 - Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title:
The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
Draft review available…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
December 20, 2017 - Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title:
The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management
Draft review available…
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-updates/methods
December 01, 2019 - A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2008_MaskedStats_Core.PDF
January 01, 2008 - neck 2,256 0.01
12: Cancer of esophagus 1,479 0.01
13: Cancer of stomach 2,289 0.01
14: Cancer of colon
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_Core.PDF
April 09, 2010 - neck 2,231 0.01
12: Cancer of esophagus 1,364 0.01
13: Cancer of stomach 2,241 0.01
14: Cancer of colon
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_Core.PDF
January 01, 2007 - neck 2,320 0.01
12: Cancer of esophagus 1,397 0.01
13: Cancer of stomach 2,297 0.01
14: Cancer of colon
-
monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
talkingquality.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
ahrqpubs.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
patientregistry.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon
-
teamstepps.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Circulating Tumor DNA
Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon … s41586-020-2140-0
36
screening technologies, such as newer stool-based tests, CT colonography, or colon